-- 宏盟集团 (OMC) 周二宣布，将扩大与 Adobe (ADBE) 的全球合作伙伴关系，共同开发一款企业级、行业专用的 AI 智能体运营模式解决方案。 宏盟集团表示，将把旗下营销和销售平台 Omni 及其智能体框架与 Adobe 的企业营销和创意技术栈整合，以打造这一解决方案。 据该公司称，未来 12 个月内，宏盟集团将在五大主要应用场景中开发并部署该解决方案，包括端到端客户体验、全渠道规划、完整创意工作流程、.com 和电子邮件。 该公司表示，该解决方案将实现 Adobe 产品、Omni 的互联平台层及其智能体基础设施之间的流畅数据交换，从而在企业级规模上实现预测性增长。
Price: $78.09, Change: $-0.41, Percent Change: -0.52%
Oneview Healthcare (ASX:ONE) reported cash receipts from customers of about 3.3 million euros for the first quarter, compared with 4.2 million euros a year earlier, according to a Monday filing with the Australian bourse.The company noted that the year-ago figure includes two large customer receipts totaling more than 2 million euros, which were due to be received during the fourth quarter of 2024 but were received in early 2025.Oneview Healthcare ended March with a cash balance of AU$17.1 million, up from AU$8.1 million at the close of 2025, per the filing.The company's shares gained 3% in recent Monday trade.
Paradigm Biopharmaceuticals (ASX:PAR) is set to progress participants through the day 112 follow-up period for the phase three trial evaluating injectable pentosan polysulfate sodium for the treatment of pain associated with knee osteoarthritis in the June quarter, which is required for inclusion in the interim analysis dataset, according to a Monday Australian bourse filing.The independent statistical analysis results for the data set are expected around August. Timing remains subject to the scheduling and review processes of independent third parties, and there is a reasonable likelihood that final interim outcomes may extend into September, it cautioned.The interim analysis is expected to provide the first phase three evaluation of efficacy and safety for injectable pentosan polysulfate sodium in knee osteoarthritis. Primary endpoint top-line results are expected in the March 2027 quarter.Its shares fell 14% in recent trading on Monday, reaching their lowest point in over a year.
Sanan Optoelectronics (SHA:600703) posted first-quarter attributable net profit of 67.5 million yuan, down 68% from 211.9 million yuan the previous year.Earnings per share declined to 0.01 yuan from 0.04 yuan, according to a weekend filing with the Shanghai bourse.Operating revenue declined 33% year over year to 2.91 billion yuan from 4.31 billion yuan.Shares of the software company declined 2% in recent trade.